首站-论文投稿智能助手
典型文献
Anticancer drug screening of natural products: In vitro cytotoxicity assays, techniques, and challenges
文献摘要:
Natural products include several diverse compounds that have been found to be effective against cancer. Discovering anticancer compounds in nature is a multistep and complex process that requires pre-clinical and clinical studies. Only a few of the available natural products are used to treat cancer since most of them have very high complexity and low bioavailability. Therefore, the process of anticancer drug discovery requires a straightforward and effective method to assess anticancer activity using in vitro assays. This review summarizes various cell-based assays and techniques used to measure cell viability, migration, and apoptosis, focusing in particular on the principles, mechanisms, advantages, and disadvantages of each assay to provide a preliminary platform for cancer drug discovery.
文献关键词:
作者姓名:
Agustina Setiawati;Damiana Sapta Candrasari;F.D.Erika Setyajati;Vincentia Krisnina Prasetyo;Dewi Setyaningsih;Yustina Sri Hartini
作者机构:
Faculty of Pharmacy,Sanata Dharma University,Paingan,Maguwoharjo,Depok,Sleman,Yogyakarta 55282,Indonesia
引用格式:
[1]Agustina Setiawati;Damiana Sapta Candrasari;F.D.Erika Setyajati;Vincentia Krisnina Prasetyo;Dewi Setyaningsih;Yustina Sri Hartini-.Anticancer drug screening of natural products: In vitro cytotoxicity assays, techniques, and challenges)[J].亚太热带生物医学杂志(英文版),2022(07):279-289
A类:
B类:
Anticancer,drug,screening,natural,products,In,vitro,cytotoxicity,assays,techniques,challenges,Natural,include,several,diverse,compounds,that,have,been,found,effective,against,Discovering,anticancer,nature,multistep,process,requires,clinical,studies,Only,few,available,are,used,treat,since,most,them,high,complexity,low,bioavailability,Therefore,discovery,straightforward,method,assess,activity,This,review,summarizes,various,cell,measure,viability,migration,apoptosis,focusing,particular,principles,mechanisms,disadvantages,each,provide,preliminary,platform
AB值:
0.617598
相似文献
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
Yu Yu;Minzhen Tao;Libin Xu;Lei Cao;Baoyu Le;Na An;Jilin Dong;Yajie Xu;Baoxing Yang;Wei Li;Bing Liu;Qiong Wu;Yinying Lu;Zhen Xie;Xiaohua Lian-Department of Cell Biology,Basic Medical College,Army Medical University(Third Military Medical University),Chongqing 400038,China;MOE Key Laboratory of Bioinformatics and Bioinformatics Division,Center for Synthetic and System Biology,Department of Automation,Beijing National Research Center for Information Science and Technology,Tsinghua University,Beijing 100084,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Thoracic Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China;Beijing Syngentech Co.,Ltd,Beijing 102206,China;School of Life Sciences,Tsinghua University,Beijing 100084,China;The Comprehensive Liver Cancer Center,The 5th Medical Center of PLA General Hospital,Beijing 100039,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants
Hong Wang;Zhe Chang;Guo-di Cai;Ping Yang;Jiang-he Chen;Shan-shu Yang;Yin-feng Guo;Ming-yu Wang;Xue-hua Zheng;Jin-ping Lei;Pei-qing Liu;De-peng Zhao;Jun-jian Wang-School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou 510006,China;State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangzhou 510060,China;Department of Pathology,Sun Yat-sen University Cancer Center,Guangzhou 510060,China;Key Laboratory of Molecular Target and Clinical Pharmacology,School of Pharmaceutical Sciences and the Fifth Affiliated Hospital,Guangzhou Medical University,Guangzhou 510006,China;Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou 510006,China;National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation,Sun Yat-sen University,Guangzhou 510006,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。